BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2020 8:47:30 AM | Browse: 936 | Download: 2532
 |
Received |
|
2020-07-04 11:58 |
|
Peer-Review Started |
|
2020-07-04 11:58 |
|
First Decision by Editorial Office Director |
|
2020-07-24 03:12 |
|
Return for Revision |
|
2020-07-24 03:12 |
|
Revised |
|
2020-07-29 14:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-08-24 12:11 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-08-25 23:06 |
|
Articles in Press |
|
2020-08-25 23:06 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-09-01 07:25 |
|
Publish the Manuscript Online |
|
2020-09-04 08:47 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Review |
| Article Title |
Autoimmunity as the comet tail of COVID-19 pandemic
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rossella Talotta and Erle Robertson |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rossella Talotta, MD, PhD, Senior Researcher, Department of Clinical and Experimental Medicine, Rheumatology Unit, AOU “Gaetano Martino”, University of Messina, via Consolare Valeria 1, Messina 98100, Italy. talotta1@virgilio.it |
| Key Words |
COVID-19; SARS-CoV-2; Autoimmunity; Autoimmune diseases; Rheumatic diseases; Host-virus interaction |
| Core Tip |
The immune system plays a central role in coronavirus disease 2019 (COVID-19), being responsible for clinical manifestations and prognosis. Hyper-activation of the immune response against severe acute respiratory syndrome coronavirus 2 may result, in some cases, in development of unwanted autoimmune disorders. COVID-19 has been associated with immune-mediated systemic or organ-selective manifestations, some of which fulfill the diagnostic or classification criteria of specific autoimmune diseases. Though it is still unknown whether these medical conditions represent transitory post-infectious epiphenomena, the use of therapeutic agents targeting the immune system may perhaps prevent their chronicization which leads to development of autoimmune diseases. |
| Publish Date |
2020-09-04 08:47 |
| Citation |
Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases 2020; 8(17): 3621-3644 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i17/3621.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i17.3621 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
